Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One DNA Way, MS34
South San Francisco, CA 94080Phone+1 415-225-1000- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 1989 - 1992
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1986 - 1989- Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1989 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Alumni Medal Northwestern University, 2020
- Alumni Achievement Award Washington University School of Medicine, 2019
- Investigator Alumnus Howard Hughes Medical Institute, 1994
Publications & Presentations
PubMed
- 24 citationsAutoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapyRafael Cubas, Zia Khan, Qian Gong, Marina Moskalenko, Huizhong Xiong, Qinglin Ou, Christine Pai, Ryan Rodriguez, Jeanne Cheung, Andrew C. Chan> ;Journal for Immunotherapy of Cancer. 2020 Oct 1
- 1095 citationsImmunology of COVID-19: Current State of the Science.Nicolas Vabret, Graham J. Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, Rachel Levantovsky, Louise Malle, Alvaro Moreira, Matthew D. Park, Luisanna Pia...> ;Immunity. 2020 Jun 16
- 11 citations30 Years of Biotherapeutics Development-What Have We Learned?Nico Ghilardi, Rajita Pappu, Joseph R. Arron, Andrew C. Chan> ;Annual Review of Immunology. 2020 Apr 26
- Join now to see all
Journal Articles
- 30 years of biotherapeutics development- what have we learnedNico Ghilardi, Rajita Pappu, Joseph Arron, Andrew C Chan, Annual Review of Immunology, 4/2020
- Ocrelizumab: A New Therapeutic Paradigm for Multiple SclerosisChin, P and Chan, AC, Biochemistry, 2/6/2018
- Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling.Holmes DA, Suto E, Lee WP, Ou Q, Gong Q, Smith HR, Caplazi P, Chan AC., Journal of Experimental Medicine, 6/29/2015
- Join now to see all
Books/Book Chapters
Grant Support
- SYK In Lymphocyte ActivationNational Institute Of Allergy And Infectious Diseases2000–2002
- BLNK Proteins In B Cell Receptor FunctionNational Institute Of Allergy And Infectious Diseases1998–2002
- Role Of SYK Protein Tyrosine Kinase In Immune FunctionNational Institute Of Allergy And Infectious Diseases2000–2001
- ZAP70 In T Cell DevelopmentNational Cancer Institute1998–2001
- Activation Mechanisms Of The SKY Protein Tyrosine KinaseNational Cancer Institute1996–1998
- ZAP-70, A T Cell Receptor Zeta Chain Associated ProteinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
